This inventor holds 5 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Hiroshima University, The University of Tokyo, Tokyo University of Pharmacy & Life Sciences. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 258 
3 out of 1,356 
3 out of 9 Years Active: 2021-2026
Title: Yusuke Nakatsu: Innovator in Therapeutic Agents
Introduction
Yusuke Nakatsu is a prominent inventor based in Hiroshima, Japan. He has made significant contributions to the field of pharmaceutical sciences, particularly in developing therapeutic agents for inflammatory diseases and cancer. With a total of four patents to his name, Nakatsu's work is paving the way for innovative treatments.
Latest Patents
Among his latest patents are an anthranilic acid-based compound and a Pin1 inhibitor. These inventions aim to develop novel drug-candidate compounds that inhibit the functions of Pin1. The inventions provide a compound represented by a specific formula or a salt thereof, along with a Pin1 inhibitor, a pharmaceutical composition, and therapeutic or prophylactic agents for inflammatory diseases, cancer, and adiposity.
Career Highlights
Yusuke Nakatsu has worked at prestigious institutions such as Hiroshima University and Tokyo University of Pharmacy & Life Sciences. His research focuses on creating effective therapeutic agents that can significantly impact patient care and treatment outcomes.
Collaborations
He has collaborated with notable colleagues, including Tomoichiro Asano and Hisanaka Ito, to advance his research and innovations in the field.
Conclusion
Yusuke Nakatsu's contributions to the development of therapeutic agents highlight his role as an influential inventor in the pharmaceutical industry. His innovative work continues to inspire advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile